Iron Financial LLC lifted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,930 shares of the pharmacy operator’s stock after buying an additional 1 shares during the quarter. Iron Financial LLC’s holdings in Walgreens Boots Alliance were worth $229,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Waldron LP increased its stake in Walgreens Boots Alliance by 67.7% in the first quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock worth $373,000 after purchasing an additional 1,816 shares during the period. Oregon Public Employees Retirement Fund lifted its position in shares of Walgreens Boots Alliance by 0.8% during the first quarter. Oregon Public Employees Retirement Fund now owns 89,716 shares of the pharmacy operator’s stock worth $7,451,000 after purchasing an additional 679 shares during the last quarter. Beaumont Financial Partners LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth $263,000. Verity & Verity LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth $278,000. Finally, North Star Investment Management Corp. lifted its position in shares of Walgreens Boots Alliance by 15.7% during the first quarter. North Star Investment Management Corp. now owns 46,704 shares of the pharmacy operator’s stock worth $3,879,000 after purchasing an additional 6,344 shares during the last quarter. Hedge funds and other institutional investors own 60.16% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 77.22 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $89.69. The firm has a market cap of $82.63 billion, a P/E ratio of 19.50 and a beta of 1.26. The firm has a 50-day moving average price of $81.36 and a 200 day moving average price of $81.86.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.18 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.07%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

Several brokerages recently issued reports on WBA. Credit Suisse Group reissued a “buy” rating and issued a $97.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. UBS AG reaffirmed a “buy” rating and set a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Royal Bank Of Canada assumed coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 target price for the company. Finally, BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $92.06.

In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 13.50% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-stake-raised-by-iron-financial-llc/1602140.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.